1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow folfirinox: new trials by email Literature Review of folfirinox trials Research Report on folfirinox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer FOLFIRINOX, Algenpantucel-L Immunotherapy, 5-FU Chemoradiation - Pancreatic Cancer, Pancreatic Carcinoma Non-resectable | Phase 3 | Terminated | NewLink Genetics Corporation | 302 | 2013-05-01 | 2020-05-28 |
NewLink Genetics Corporation (1)
United States (1)